BioLargo, Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue of BioLargo, Inc. on 31/03/2021 amounted to 571 000 $. BioLargo, Inc. net income is now -1 633 000 $. The dynamics of BioLargo, Inc. net income fell by -7 000 $. The assessment of the dynamics of BioLargo, Inc. net income was made in comparison with the previous report. Chart of online financial report of BioLargo, Inc.. BioLargo, Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. BioLargo, Inc. total revenue on the graph is shown in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
571 000 $
+56.87 % ↑
-1 633 000 $
-
31/12/2020
910 000 $
+83.02 % ↑
-1 626 000 $
-
30/09/2020
666 000 $
+24.72 % ↑
-2 106 000 $
-
30/06/2020
418 000 $
-1.878 % ↓
-2 426 000 $
-
30/09/2019
534 000 $
-
-3 679 000 $
-
30/06/2019
426 000 $
-
-1 795 000 $
-
31/03/2019
364 000 $
-
-2 576 000 $
-
31/12/2018
497 207 $
-
-2 131 809 $
-
30/09/2018
277 026 $
-
-2 261 688 $
-
30/06/2018
326 738 $
-
-3 504 579 $
-
Show:
to
BioLargo, Inc. financial report charts
The latest dates of BioLargo, Inc. financial statements available online: 30/06/2018, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of BioLargo, Inc. is available online for such a date - 31/03/2021. Gross profit BioLargo, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit BioLargo, Inc. is 232 000 $
BioLargo, Inc. quarterly report dates
Cost of revenue BioLargo, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue BioLargo, Inc. is 339 000 $ Total revenue BioLargo, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue BioLargo, Inc. is 571 000 $ Operating income BioLargo, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income BioLargo, Inc. is -1 858 000 $
Net income BioLargo, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income BioLargo, Inc. is -1 633 000 $ Current assets BioLargo, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets BioLargo, Inc. is 1 922 000 $ Total assets BioLargo, Inc. refers to the total amount of assets owned by a person or entity. Total assets BioLargo, Inc. is 5 337 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
232 000 $
467 000 $
365 000 $
217 000 $
268 000 $
198 000 $
172 000 $
239 857 $
155 480 $
125 826 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
339 000 $
443 000 $
301 000 $
201 000 $
266 000 $
228 000 $
192 000 $
257 350 $
121 546 $
200 912 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
571 000 $
910 000 $
666 000 $
418 000 $
534 000 $
426 000 $
364 000 $
497 207 $
277 026 $
326 738 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-1 858 000 $
-1 966 000 $
-1 844 000 $
-1 961 000 $
-1 822 000 $
-1 487 000 $
-1 662 000 $
-1 514 294 $
-1 593 986 $
-1 628 891 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-1 633 000 $
-1 626 000 $
-2 106 000 $
-2 426 000 $
-3 679 000 $
-1 795 000 $
-2 576 000 $
-2 131 809 $
-2 261 688 $
-3 504 579 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
327 000 $
307 000 $
347 000 $
350 000 $
332 000 $
367 000 $
426 000 $
328 335 $
443 359 $
425 576 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
2 429 000 $
2 876 000 $
2 510 000 $
2 379 000 $
2 356 000 $
1 913 000 $
2 026 000 $
2 011 501 $
1 871 012 $
1 955 629 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
1 922 000 $
1 505 000 $
1 873 000 $
1 678 000 $
2 566 000 $
1 001 000 $
782 000 $
955 000 $
752 328 $
823 302 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
5 337 000 $
4 942 000 $
5 188 000 $
4 896 000 $
5 104 000 $
3 583 000 $
3 395 000 $
3 185 000 $
1 088 885 $
1 167 608 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
1 341 000 $
716 000 $
1 117 000 $
1 207 000 $
2 136 000 $
706 000 $
512 000 $
655 000 $
533 542 $
651 061 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
4 757 000 $
4 474 000 $
3 125 000 $
2 491 000 $
1 828 313 $
943 489 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
6 114 000 $
5 502 000 $
5 188 000 $
4 308 000 $
2 069 757 $
1 812 059 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
119.79 %
153.56 %
152.81 %
135.26 %
190.08 %
155.19 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
4 749 000 $
3 858 000 $
4 677 000 $
2 635 000 $
-1 120 000 $
-2 127 000 $
-2 082 000 $
-1 496 000 $
-1 355 549 $
-1 137 175 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-1 330 000 $
-982 000 $
-869 000 $
-839 712 $
-998 177 $
-1 057 480 $
Last revenue report of BioLargo, Inc. was 31/03/2021. According to last financial report total revenue in BioLargo, Inc. was 571 000 US dollar and changed by +56.87% since last year. Net income in BioLargo, Inc. was -1 633 000 $ in last quartal, net income changes to 0%.
Current cash BioLargo, Inc. - the sum of all of the cash a company has on the date of report. Current cash BioLargo, Inc. is 1 341 000 $
BioLargo, Inc. stocks data
BLGO stock price
BioLargo, Inc. stock price today, BLGO stock quote.
